SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Diabetics and healthcare advocates rally on November 14, 2019--World Diabetes Day--in New York City as part of the Lower Drug Prices Now Campaign's National Day of Action. (Photo: Erik McGregor/LightRocket via Getty Images)
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."
Donald Trump’s attacks on democracy, justice, and a free press are escalating — putting everything we stand for at risk. We believe a better world is possible, but we can’t get there without your support. Common Dreams stands apart. We answer only to you — our readers, activists, and changemakers — not to billionaires or corporations. Our independence allows us to cover the vital stories that others won’t, spotlighting movements for peace, equality, and human rights. Right now, our work faces unprecedented challenges. Misinformation is spreading, journalists are under attack, and financial pressures are mounting. As a reader-supported, nonprofit newsroom, your support is crucial to keep this journalism alive. Whatever you can give — $10, $25, or $100 — helps us stay strong and responsive when the world needs us most. Together, we’ll continue to build the independent, courageous journalism our movement relies on. Thank you for being part of this community. |
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."
As a new survey published Tuesday showed overwhelming support among American voters for capping the cost of insulin at $35 per month, progressive U.S. lawmakers underscored what they insisted is the Senate's imperative to include a provision allowing Medicare to negotiate lower drug prices in its version of the Build Back Better budget reconciliation bill.
The Data for Progress poll found that 87% of all respondents--including 94% of self-described Democrats, 84% of Independents, and 82% of Republicans--"strongly" or "somewhat" favor the insulin price cap.
Writing for Data for Progress, Sen. Ron Wyden (D-Ore.) noted that the House version of the Build Back Better Act, which was passed last week, "will allow Medicare to negotiate the prices of certain pharmaceuticals, including insulin."
\u201cNEW POLL: An overwhelming majority of voters support capping insulin costs at $35 per month \u2014 a proposal included in the Build Back Better Act.\n\nThat includes Independents by a +76-point margin and Republicans by a +71-point margin.\u201d— Data for Progress (@Data for Progress) 1637687244
"It also creates a cap so that no one pays more than $35 per month for insulin," he continued. "Let me say that again: House Democrats just passed a cap on the price of insulin at $35 per month--and now it's time for the Senate to get it done."
"American families currently pay thousands of dollars a year for their insulin, far more than any other nation," said Wyden, "even though its estimated cost of manufacturing is just $2.28 to $6.34 per vial, the sticker price for a single vial of insulin is $300. That's hundreds of dollars a month out of the pockets of millions of families in Oregon and families across the country for a drug that's been around for decades due to the uncontrolled greed of the pharmaceutical industry."
"The effects are disastrous," he added. "For instance, one quarter of Americans with Type 1 diabetes ration their insulin due to its exorbitant costs. By capping the price of insulin at $35 per month, the Build Back Better Act can help millions of Americans get the insulin they need at a price they can afford."
\u201cThe Build Back Better Act will cap out-of-pocket insulin costs at $35 per month. \n\nThinking of Alec Smith, a Minnesota restaurant manager who tragically passed away because he couldn\u2019t afford the cost of his insulin.\n\nThis insulin cap is for him and so many others.\u201d— Rep. Ilhan Omar (@Rep. Ilhan Omar) 1637681458
Senate Budget Committee Chair Bernie Sanders (I-Vt.) tweeted Tuesday that "insulin should not cost 10 times as much in the United States as it does in Canada. Period."